The institute's Scientific Advisory Board

To ensure the high quality of scientific research in the long term, all institutes of the Max Planck Society are regularly reviewed by independent advisory boards. Tailored to the respective field of research, the advisory board is composed of experts from leading research institutions and universities worldwide. The Advisory Board evaluates the resource allocation of the departments and research groups. This ensures that only cutting-edge research areas of the highest international standard are addressed. The members of the Advisory Board are selected by the President of the Max Planck Society on the basis of proposals from the institute and appointed for a maximum term of six years, with a replacement of some of the members every three years..

These are the members of the institute’s advisory board:

• Prof. Dr. Rui Costa 
  Allen Institute, Seattle, USA

• Prof. Dr. Yang Dan  
  Shenzhen Medical Academy of Research and Translation, Institute of Neuromodulation and Cognition, Guangming Life Science Park, Guangming, China

• Prof. Dr. Vivek Jayaraman 
  Howard Hughes Medical Institute, Janelia Research Campus, Ashburn, USA

• Prof. Dr. Walter D. Koenig 
  Lab of Ornithology, Cornell University, Carmel Valley, USA

• Prof. Dr. Adriana Maggi
  Molecular Pharmacology Lab, Università degli Studi di Milano, Milano, Italy

• Prof. Dr. Oscar Marin 
  MRC Centre for Developmental Neurobiology, King’s College London, London, UK

• Prof. Dr. Richard Daniel Mooney
  Duke University Department of Neurobiology, Durham, USA

• Prof. Dr. Hitoshi Okamoto
  RIKEN Center for Brain Science, Saitama, Japan

• Prof. Dr. Naomi Pierce
  Harvard University Department of Organismic and Evolutionary Biology, Museum of Comparative Zoology, Cambridge, USA

• Prof. Dr. Christina Riehl
  Princeton University Department of Ecology and Evolutionary Biology, Princeton, USA